FDA Inspection 1313292 - Molecular Imaging Program at Stanford - April 17, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Molecular Imaging Program at Stanford

Record Details

This FDA Inspection record concerns Molecular Imaging Program at Stanford, with an inspection on April 17, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Molecular Imaging Program at Stanford
Inspection Date: April 17, 2026
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · 6d9cc2e0-590c-43fd-8031-959c5ba5d7ec

Violation Codes6

21 CFR 212.20(e)21 CFR 212.40(c)21 CFR 212.50(c)(4)21 CFR 212.60(a)21 CFR 212.60(b)21 CFR 212.70(d)(1)

Full citation text and observation details available on the Dashboard.